Manual therapy for chronic tension-type headache.

Effectiveness of treatment for chronic tension-type headache by the general practitioner or a manual therapist: design of a randomised clinical trial.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON28215

Enrollment

Registered

2007-09-28

Start date

2007-06-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic tension-type headache (chronische spierspanningshoofdpijn).

Interventions

Manual therapy treatment includes a combination of mobilisation of the cervical and thoracic spine, exercises and posture correction Spinal mobilisations consist of low and/or high-velocity cervical a

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 65 years; 2. Chronic tension type headache according to the classification of the International Headache Society 2004 2nd edition: headache occurring on at least 15 days on average per month for a period of more than 3 months (>180 days a year), headache lasts for hours or may be continuous. The headache has at least one of the following characteristics: 1. bilateral location; 2. pressing/tightening (non pulsating) quality; 3. mild or moderate intensity, not aggravated by normal physical activities such as walking or climbing stairs. Both of the following: 1. no more than one of photofobia, phonophobia or mild nausea, and 2. neither moderate or severe nausea nor vomiting. 3. able to read and write Dutch; 4. informed consent.

Exclusion criteria

Exclusion criteria: 1. Reumatoid artritis; 2. Suspicion of malignity; 3. Pregnancy; 4. Intake of either triptans, ergotamines or opioids on ¡Ý10 days/month or simple analgesics on ¡Ý15 days/month on a regular basis for ¡Ý3 months; 5. Manual therapy treatment in the 2 months before inclusion.

Design outcomes

Primary

Measure	Time frame
Outcome measures are assessed after 8 and 26 weeks after randomisation: 1. the frequency of days with headache; 2. use of pain medication (no. of pills NSAIDs or simple analgesics) over a period of 2 weeks, both scored by the patient in a headache diary.	—

Secondary

Measure	Time frame
1. Headache pain intensity measured on a 0-10 point numerical rating scale; 2. impact of headache on daily life using the Headache Disability Inventory (HDI) and the Headache Impact Test-6(Hit-6); 3. active range of movement in flexion, extension, right and left rotation, and right and left lateroflexion of the cervical spine measured with a CROM-device; 4. algometry on the trapezius descendens and the suboccipital muscle with a Wagner FDK algometer; 5. endurance of neck flexor muscles scored as the number of seconds the patient can raise his head from the table when lying on his back; 6. craniocervical angle (digital photography); 7. use of additional medical resources.	—

Measure

Time frame

1. Headache pain intensity measured on a 0-10 point numerical rating scale; 2. impact of headache on daily life using the Headache Disability Inventory (HDI) and the Headache Impact Test-6(Hit-6); 3. active range of movement in flexion, extension, right and left rotation, and right and left lateroflexion of the cervical spine measured with a CROM-device; 4. algometry on the trapezius descendens and the suboccipital muscle with a Wagner FDK algometer; 5. endurance of neck flexor muscles scored as the number of seconds the patient can raise his head from the table when lying on his back; 6. craniocervical angle (digital photography); 7. use of additional medical resources.

—

Contacts

Public ContactDaniëlle Windt van der

EMGO Institute, VU University medical centre Van der Boechorststraat 7

dawm.vanderwindt@vumc.nl+31 20 444 8354

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)